Skip to main content
Matchbox
BCAL Diagnostics banner
BCAL Diagnostics logo

BCAL Diagnostics

BCAL Diagnostics is a biotechnology company that focuses on the detection of women’s health issues.

Backed by

Ellerston CapitalEllerston Capital
APS FoundationAPS Foundation
Mark McConnellMark McConnell

Raised 10.5M EQUITY on June 2, 2024

About

BCAL Diagnostics is a publicly listed biotechnology company developing breast cancer diagnostic tests and related technologies.

Mission

BCAL Diagnostics is a listed breast cancer biotech. The company has closed an oversubscribed fundraising round totalling $10.5 million. The raise was supported by existing backers including Ellerston Capital, APS Foundation and tech entrepreneur Mark McConnell. BCAL initially sought $5 million but was able to raise roughly twice that amount. The company will seek shareholder approval on July 15 for proceeds that fell outside its annual placement capacity. The article does not disclose operating metrics, product details, or use of proceeds.

Quick Facts

Founded

2010

Funding

EQUITY

Industry

Biotechnology, Clinical Trials, Health Care, Health Diagnostics, Women's

Team Size

11-50

Headquarters

Sydney, New South Wales, Australia

Careers

View Careers Page
BCAL Diagnostics logo

No open roles at this time.

Check their careers page for updates